Comparison of anaerobic, cycling aerobic/anoxic, and sequential anaerobic/aerobic/anoxic digestion to remove triclosan and triclosan metabolites from municipal biosolids

Occurrence, spatiotemporal trends, fate, and treatment technologies for microplastics and organic contaminants in biosolids: A review

This review provides a comprehensive overview of the occurrence, fate, treatment and multi-criteria analysis of microplastics (MPs) and organic contaminants (OCs) in biosolids. A meta-analysis was complementarily analysed through the literature to map out the occurrence and fate of MPs and 10 different groups of OCs. The data demonstrate that MPs (54.7% occurrence rate) and linear alkylbenzene sulfonate surfactants (44.2% occurrence rate) account for the highest prevalence of contaminants in biosolids. In turn, dioxin, polychlorinated biphenyls (PCBs) and phosphorus flame retardants (PFRs) have the lowest rates (<0.01%). The occurrence of several OCs (e.g., dioxin, per- and polyfluoroalkyl substances, polycyclic aromatic hydrocarbons, pharmaceutical and personal care products, ultraviolet filters, phosphate flame retardants) in Europe appear at higher rates than in Asia and the Americas. However, MP concentrations in biosolids from Australia are reported to be 10 times higher than in America and Europe, which required more measurement data for in-depth analysis. Amongst the OC groups, brominated flame retardants exhibited exceptional sorption to biosolids with partitioning coefficients (log Kd) higher than 4. To remove these contaminants from biosolids, a wide range of technologies have been developed. Our multicriteria analysis shows that anaerobic digestion is the most mature and practical. Thermal treatment is a viable option; however, it still requires additional improvements in infrastructure, legislation, and public acceptance.

Quantifying the removal of polybrominated diphenyl ethers (PBDEs) in physical, chemical, and biological sludge treatment systems

Polybrominated diphenyl ethers (PBDE) are priority contaminants historically used as flame retardants. PBDEs are known to occur in wastewater biosolids posing potential concerns with the beneficial land application of the biosolids. This study evaluated the removal of 21 congeners in nine full-scale sludge treatment systems including pelletization (P), alkaline stabilization (AS), and aerobic (AE) and anaerobic (AN) digestion. It is the first study to conduct a mass balance analysis of a broad spectrum of PBDEs during physical, chemical, and biological sludge treatment. The PBDE congener pattern in raw sludge and biosolids samples was consistent with commercial formulations. The fully brominated congener BDE-209 dominated biosolids from all sites with an average concentration of 620 ng/g dry weight (dw), followed by BDE-99 (173 ng/g dw) and BDE-47 (162 ng/g dw). Mass balance analysis on the P and AS processes showed no change in PBDE mass flows with treatment. However, aerobic and anaerobic digestion processes reported significant levels of removal and formation of individual congeners, though the results were not consistent between facilities. One aerobic digestion process (AE2) reported an overall average removal of 48%, whereas the other (AE1) reported very high levels of accumulation of tri- and tetraBDE congeners. Similarly, there were significant variations in PBDE behavior across the five anaerobic digestion plants studied. The plant with the longest solids retention time (SRT) (AN1) reported a moderate removal (50%) of overall PBDE loading and lower congeners, whereas other plants (AN2-AN5) showed significant low (-19%) to high (-166%) levels of formation of lower congeners. The results suggest that reduced SRTs result in formation of lower congeners while extended SRTs can lead to moderate removal of some PBDEs. Conventional sludge treatment result in low to moderate PBDE removal and advanced thermal conversion technologies may be needed to improve the contaminant removal during sludge treatment.

Performance assessment of a modified trickling filter and conventional activated sludge process along with tertiary treatment in removing emerging pollutants from urban sewage

The absence of effective wastewater treatment technology to eliminate emerging pollutants from municipal sewage has become a pressing issue. In this study, the efficacy of a novel modified trickling filter (MTF), conventional activated sludge process (ASP) and two tertiary systems (UV and ozonation) were compared in eliminating antibiotic-resistant bacteria (ARB), antibiotic resistance genes (ARGs) and pharmaceuticals and personal care products (PPCPs) from urban sewage. MTF and ASP resulted in >1 log unit reduction in the abundance of ARB, while for ARGs, the removal was observed in the range of 0.1 to 1.7 log units. In MTF, ARGs were substantially removed in the aerobic zone compared to the anoxic zone. The relative abundance of most of the ARGs either decreased or remained unchanged during MTF and ASP operations. However, the relative abundance of most of the ARGs increased in the secondary sludge generated from ASP. The concentration of PPCPs such as atenolol, sulfamethazine, triclosan, and ranitidine was reduced by MTF by >80 %. Overall, the results indicated that MTF followed by ozonation is the most effective combination for removing emerging contaminants from municipal sewage.

Sewage-Water Treatment and Sewage-Sludge Management with Power Production as Bioenergy with Carbon Capture System: A Review

Sewage-water treatment comprehends primary, secondary, and tertiary steps to produce reusable water after removing sewage contaminants. However, a sewage-water treatment plant is typically a power and energy consumer and produces high volumes of sewage sludge mainly generated in the primary and secondary steps. The use of more efficient anaerobic digestion of sewage water with sewage sludge can produce reasonable flowrates of biogas, which is shown to be a consolidated strategy towards the energy self-sufficiency and economic feasibility of sewage-water treatment plants. Anaerobic digestion can also reduce the carbon footprint of energy sources since the biogas produced can replace fossil fuels for electricity generation. In summary, since the socio-economic importance of sewage treatment is high, this review examined works that contemplate: (i) improvements of sewage-water treatment plant bioenergy production and economic performances; (ii) the exploitation of technology alternatives for the energy self-sufficiency of sewage-water treatment plants; (iii) the implementation of new techniques for sewage-sludge management aiming at bioenergy production; and (iv) the implementation of sewage-water treatment with bioenergy production and carbon capture and storage.

COVID-19 and antimicrobial resistance: A cross-study

Antimicrobial resistance (AMR) is emerging as a severe concern due to the escalating instances of resistant human pathogens encountered by health workers. Consequently, there is a shortage of antibiotics to treat Multidrug Resistance (MDR) and Extensively Drug Resistance (XDR) patients. The primary cause of AMR is the vast array of anthropogenic disturbances in natural microfauna brought about by the extensive use of antibiotics. Coronavirus Disease of 2019 (COVID-19) has crashed antibiotic stewardship and single-handedly increased the global usage of antibiotics, Personal Protective Equipment (PPE), and biocide, causing a ripple effect in the existing global AMR problem. This surge in antibiotic usage has escalated the residual antibiotics reaching Wastewater Treatment Plants (WWTPs) from pharmaceutical companies, health care centers, and domestic settings. Ultimately the natural water bodies receiving their effluents will have higher concentrations of emerging contaminants as the WWTPs cannot remove the Pharmaceuticals and Personal Care Products (PPCPs) completely. Furthermore, increased biocides usage will increase AMR by co-resistance, and increasing plastics will turn into microplastics and get converted to plastisphere, which will further enhance its propagation. Therefore, it is crucial to curb antibiotic usage, implement antibiotic stewardship dynamically; and, ameliorate the present condition of WWTPs to remove residual PPCPs efficiently. The need of the hour is to address the grave threat of AMR, which is loitering silently; if not the mankind will endure more affliction hereafter.

Examination of single-stage anaerobic and anoxic/aerobic and dual-stage anaerobic-anoxic/aerobic digestion to remove pharmaceuticals from municipal biosolids

Many trace contaminants of emerging concern (CECs) including a number of pharmaceutically active compounds are not effectively removed during conventional wastewater treatment processes and instead accumulate in wastewater sludge. Unfortunately, many existing sludge stabilization treatments such as anaerobic digestion (AD) also have limited effectiveness against many of these CECs including the four pharmaceuticals ibuprofen, diclofenac, carbamazepine, and azithromycin which can then enter the environment through the disposal or land application of biosolids. Single-stage AD, single-stage cycling aerobic-anoxic (AERO/ANOX) and sequential digesters (AD followed by an AERO/ANOX digester) at sludge retention times (SRT) of 5 to 20-days were evaluated side-by-side to assess their effectiveness in removing pharmaceuticals and conventional organic matter. Single-stage ADs (35 °C) and AERO/ANOX (22 °C) digesters effectively removed total solids while sequential AD + AERO/ANOX digesters offered further improvements. Ibuprofen was not effectively removed during AD and resulted in up to a 23 ± 8% accumulation. However, ibuprofen was completely removed during AERO/ANOX digestion and in several sequential digestion scenarios. Each type of digestion was less effective against carbamazepine with slight (3 ± 2%) accumulations to low levels (14 ± 1%) of removals in each type of digestion studied. Diclofenac was more effectively removed with up 30 ± 3% to 39 ± 4% reductions in the single-stage digesters (AD and AERO/ANOX, respectively). While sequential digestion scenarios with the longest aerobic SRTs significantly increased diclofenac removals from their first-stage digesters, scenarios with the longest anaerobic SRTs actually decreased removals from first-stage digesters, possibly due to reversible biotransformation of diclofenac conjugates/metabolites. Up to 43 ± 6% of azithromycin was removed in AERO/ANOX digesters, while the best performing sequential-digester scenario removed up to 63 ± 7% of azithromycin. This study shows that different digester configurations can reduce the CEC burden in biosolids while also greatly reducing their volumes for disposal, although none can remove CECs completely.

A Review on the Fate of Legacy and Alternative Antimicrobials and Their Metabolites during Wastewater and Sludge Treatment

Antimicrobial compounds are used in a broad range of personal care, consumer and healthcare products and are frequently encountered in modern life. The use of these compounds is being reexamined as their safety, effectiveness and necessity are increasingly being questioned by regulators and consumers alike. Wastewater often contains significant amounts of these chemicals, much of which ends up being released into the environment as existing wastewater and sludge treatment processes are simply not designed to treat many of these contaminants. Furthermore, many biotic and abiotic processes during wastewater treatment can generate significant quantities of potentially toxic and persistent antimicrobial metabolites and byproducts, many of which may be even more concerning than their parent antimicrobials. This review article explores the occurrence and fate of two of the most common legacy antimicrobials, triclosan and triclocarban, their metabolites/byproducts during wastewater and sludge treatment and their potential impacts on the environment. This article also explores the fate and transformation of emerging alternative antimicrobials and addresses some of the growing concerns regarding these compounds. This is becoming increasingly important as consumers and regulators alike shift away from legacy antimicrobials to alternative chemicals which may have similar environmental and human health concerns.